Thermo Fisher Scientific (NYSE:TMO – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 21.290-22.070 for the period, compared to the consensus EPS estimate of 21.700. The company issued revenue guidance of $42.4 billion-$43.3 billion, compared to the consensus revenue estimate of $43.0 billion. Thermo Fisher Scientific also updated its FY24 guidance to $21.29-22.07 EPS.
Analysts Set New Price Targets
A number of brokerages recently commented on TMO. HSBC upped their price objective on Thermo Fisher Scientific from $660.00 to $670.00 and gave the stock a buy rating in a research note on Tuesday, April 30th. JPMorgan Chase & Co. boosted their price target on Thermo Fisher Scientific from $600.00 to $650.00 and gave the stock an overweight rating in a research report on Thursday, April 25th. The Goldman Sachs Group boosted their price target on Thermo Fisher Scientific from $550.00 to $640.00 and gave the stock a buy rating in a research report on Wednesday, April 10th. Stifel Nicolaus upped their price objective on Thermo Fisher Scientific from $600.00 to $615.00 and gave the company a buy rating in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Thermo Fisher Scientific from $600.00 to $610.00 and gave the company a buy rating in a report on Thursday, April 25th. Five analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and an average target price of $618.94.
Get Our Latest Analysis on Thermo Fisher Scientific
Thermo Fisher Scientific Stock Up 1.8 %
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) last issued its earnings results on Wednesday, July 24th. The medical research company reported $5.37 earnings per share for the quarter, topping the consensus estimate of $5.13 by $0.24. Thermo Fisher Scientific had a return on equity of 18.22% and a net margin of 14.69%. The company had revenue of $10.54 billion for the quarter, compared to analyst estimates of $10.50 billion. During the same period in the prior year, the firm posted $5.15 EPS. The business’s revenue was down 1.4% compared to the same quarter last year. On average, research analysts expect that Thermo Fisher Scientific will post 21.64 earnings per share for the current fiscal year.
Thermo Fisher Scientific Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Friday, September 13th will be given a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 0.26%. The ex-dividend date of this dividend is Friday, September 13th. Thermo Fisher Scientific’s payout ratio is currently 10.01%.
Insider Activity
In other news, CEO Marc N. Casper sold 10,000 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $567.28, for a total transaction of $5,672,800.00. Following the transaction, the chief executive officer now owns 123,816 shares of the company’s stock, valued at approximately $70,238,340.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.34% of the stock is currently owned by insiders.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Recommended Stories
- Five stocks we like better than Thermo Fisher Scientific
- Stock Splits, Do They Really Impact Investors?
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- What is the Hang Seng index?
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.